The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
2015 · Aging Cell · 2,288 citations
https://doi.org/10.1111/acel.12344
T
Tamar Pirtskhalava
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
18.1K
Citations
36
h-index
42
i10-index
Tamar Pirtskhalava is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Telomeres, Telomerase, and Senescence & Adipokines, Inflammation, and Metabolic Diseases & Adipose Tissue and Metabolism. The author has an h-index of 36, co-authored 51 publications.
Papers by this author
worksSenolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
2019 · EBioMedicine · 1,188 citations
https://doi.org/10.1016/j.ebiom.2019.08.069
Fisetin is a senotherapeutic that extends health and lifespan
2018 · EBioMedicine · 913 citations
https://doi.org/10.1016/j.ebiom.2018.09.015
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
2017 · Aging · 687 citations
https://doi.org/10.18632/aging.101202
Targeting senescent cells alleviates obesity‐induced metabolic dysfunction
2019 · Aging Cell · 640 citations
https://doi.org/10.1111/acel.12950
Targeting senescent cells enhances adipogenesis and metabolic function in old age
2015 · eLife · 578 citations
https://doi.org/10.7554/elife.12997
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat